Order Article Reprints

Kivell BM, Paton KF, Kumar N, Morani AS, Culverhouse A, Shepherd A, Welsh SA, Biggerstaff A, Crowley RS, Prisinzano TE. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules. 2018; 23(10):2602. https://doi.org/10.3390/molecules23102602

Kivell, Bronwyn M., Kelly F. Paton, Nitin Kumar, Aashish S. Morani, Aimee Culverhouse, Amy Shepherd, Susan A. Welsh, Andrew Biggerstaff, Rachel S. Crowley, and Thomas E. Prisinzano. 2018. "Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents" Molecules 23, no. 10: 2602. https://doi.org/10.3390/molecules23102602

Kivell, B. M., Paton, K. F., Kumar, N., Morani, A. S., Culverhouse, A., Shepherd, A., Welsh, S. A., Biggerstaff, A., Crowley, R. S., & Prisinzano, T. E. (2018). Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules, 23(10), 2602. https://doi.org/10.3390/molecules23102602